UPDATE: This study has been completed with the full analysis of all 54 patients. Click here for full results. Earlier this month, during the most…
1717 K Street NW, Suite 900
Washington, DC 20006-5349
(877) 363-6376
HELPLINE
A new article reviewing progress and advances that occurred in 2017 in the management of pleural mesothelioma was just published in the May 2018 issue…
In 2004, over 14 years ago (!), the FDA approved the first ever (and the last so far) mesothelioma treatment drug – Alimta (pemetrexed) in…
We are excited to report that Congress has funded the congressionally directed Department of Defense (DoD) funding for Fiscal Year 2018 (FY18) with $80 million…
The Mesothelioma Applied Research Foundation (Meso Foundation) commends the efforts of Sen. Jeff Merkley (D-OR) and the Asbestos Disease Awareness Organization (ADAO) for the introduction of…
IMPORTANT NEWS: The board of directors of the Meso Foundation is excited to announce that Mary Hesdorffer has been appointed executive director of the Foundation.…
Time is of the essence, persistence is key, and share your story. These were just some of the key points highlighted during our recent Meet…
Running a quick internet search about what families and friends should and shouldn’t say to cancer patients yields literally thousands of results. As our staff…
In 2018, the International Symposium on Malignant Mesothelioma is once again going on tour. This year, in an effort to provide as many of you…
We are very sad to announce that today is Beth Posocco’s last day working at the Meso Foundation. Although some of you may not know…
